An Observational Study to Evaluate the Efficacy of Lodoz in a Population of Hypertensive Patients

• Status: Completed
• Trial end date: 2011-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This is an observational, prospective, non-interventional, non-randomised, open label multicentric study planned to be conducted in 1000 subjects with mild to moderate primary hypertension in approximately 20 centres in Thailand. The purpose of this study is to examine the beneficial effects of combination of bisoprolol with hydrochlorothiazide available as Lodoz in treatment of Thai subjects with mild to moderate hypertension. The outcome of the study would also provide information on the optimal daily dosage schedule as well as adherence of Lodoz.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck KGaA; Merck KGaA, Darmstadt, Germany
• Treatments: Bisoprolol; Hydrochlorothiazide

Criteria

Inclusion Criteria:

• Signed written informed consent

• Subjects diagnosed with mild to moderate essential hypertension

• Subjects foreseen for Lodoz treatment for hypertension

• Age ≥ 18 years

Exclusion Criteria:

• Subjects treated with Lodoz before study initiation

• Subjects who are pregnant

• Subjects with any known contraindications to Lodoz based on local label